BioFynder is a high-tech startup focused on the development and commercialization of innovative medical diagnostic solutions. Established in 2025, the company is headquartered in the United Kingdom and is committed to advancing global healthcare through cutting-edge technology and international collaboration.

BioFynder leverages modern biotechnologies, including immunology, molecular biology, and advanced diagnostic methodologies, to develop rapid, accurate, and user-friendly medical testing products. The company has made significant progress in building a robust product pipeline

With a state-of-the-art laboratory in the UK and long-term partnerships with R&D institutions in UK, China, Europe, and beyond, BioFynder benefits from strong technical support and a global perspective. The company is led by a dynamic team with complementary expertise: a technical founder driving product development and regulatory compliance, and a sales and business development expert focused on market expansion and customer engagement.

BioFynder is dedicated to creating a comprehensive ecosystem of R&D, production, and sales, with the vision of becoming a leading brand in the global in vitro diagnostics industry. By focusing on high-tech, innovative solutions, BioFynder aims to deliver impactful diagnostic products that empower healthcare providers and improve patient outcomes worldwide.